Profile
ChipCare is a Toronto-based pre-revenue company, developing a point-of-care platform which will have the unique capability of providing a differential diagnosis for Sexually Transmitted Infections (STIs). STIs represent more than a $1 billion market with a CAGR of 10%.
This diagnosis will inform appropriate prescription medication that can be dispensed to the patient upon completion.
We intend to place the platform in national pharmacy and retail store chain clinics and Planned Parenthood, among others.

Website
chipcare.caContact
-
Jeffrey Weisberg, President and Chief Executive OfficerTel: +1 978-257-2970Email: jweisberg@chipcare.ca
Event details
Date: September 14 - 16, 2020
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
16 in total
-
Artenga’s microbubble drug conjugates (MDC) are used with focused ultrasound (FUS) as a key…
-
ChipCare is a Toronto-based pre-revenue company, developing a point-of-care platform which will have the unique…
-
Curiato is pioneering a non-invasive patient monitoring platform for healthcare. Our platform relies on our smart bed…
-
Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided…
-
KA Imaging has created color x-ray that allows for bone and soft tissue separation similar to CT, but at a fraction of…
-
The low-cost Lumasonix Blood Test (LBT) provides crucial information about otherwise undetectable cancer…
-
Mediphage Bioceuticals is a genetic medicine company developing safe, effective, and accessible cures for chronic and…
-
Nanology Labs has developed a tumor modulating theranostic agent, Manganescan, with capability to oxygenate tumors and…
-
OPTT is a digital mental health platform equipping healthcare organizations with a comprehensive package of digital…
-
Ovensa is a Canadian preclinical stage company developing a siRNA drug candidate silencing the overexpression of…
-
SaluTech has developed a proprietary conductive biomaterial (CBM) to treat patients suffering from Atrial…
-
The SWANglide ultrasound-enhanced needle biopsy from Swan Cytologics improves patient outcomes and reduces healthcare…
-
Thornhill Medical is a Canadian designer and manufacturer of innovative healthcare technology. Our product portfolio…
-
Ventripoint Diagnostics is a medical device company engaged in the development and commercialization of a breakthrough…
-
VeriLuce Therapeutics is an early-stage company currently focusing on the computational design and development of small…
-
Vitreo Pharma is a developmental stage company that utilizes a polypharmacology strategy to generate our lead, first-in…